此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。

S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma

2020年3月20日 更新者：Southwest Oncology Group

A Phase II Trial of the Combination of OSI-774 (ERLOTINIB; NSC-718781) and Bevacizumab (Rhumab VEGF; NSC-704865) in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features (ADENOBAC)

RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Giving erlotinib together with bevacizumab may kill more tumor cells.

PURPOSE: This phase II trial is studying how well giving erlotinib together with bevacizumab works in treating patients with stage III or stage IV non-small cell lung cancer.

研究概览

地位

完全的

条件

干预/治疗

详细说明

OBJECTIVES:

Primary

  • Determine overall survival of patients with stage IIIB or IV bronchioloalveolar carcinoma (BAC) or adenocarcinoma with BAC features treated with erlotinib hydrochloride and bevacizumab.

Secondary

  • Determine the progression-free survival of patients treated with this regimen.
  • Compare, preliminarily, response as assessed by RECIST criteria vs response as assessed by a central computer-assisted image-analysis system in patients with measurable disease treated with this regimen.
  • Assess the frequency and severity of toxicities of this regimen in these patients.

OUTLINE: This is a multicenter study.

Patients receive oral erlotinib hydrochloride once daily on days 1-21 and bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed every 3 months for 1 year and then every 6 months for up to 2 years.

PROJECTED ACCRUAL: A total of 80 patients will be accrued for this study.

研究类型

介入性

注册 (实际的)

84

阶段

  • 阶段2

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习地点

  • 美国
    • California
      • Antioch、California、美国、94531
        • Kaiser Permanente - Deer Valley
      • Berkeley、California、美国、94704
        • Alta Bates Summit Comprehensive Cancer Center
      • Burlingame、California、美国、94010
        • Peninsula Medical Center
      • Fremont、California、美国、94538
        • Kaiser Permanente - Fremont
      • Hayward、California、美国、94545
        • Kaiser Permanente Medical Center - Hayward
      • Marysville、California、美国、95901
        • Tibotec Therapeutics - Division of Ortho Biotech Products, LP
      • Oakland、California、美国、94611
        • Kaiser Permanente Medical Center - Oakland
      • Pleasanton、California、美国、94588
        • Valley Medical Oncology Consultants - Pleasanton
      • Redwood City、California、美国、94063
        • Kaiser Permanente Medical Center - Redwood City
      • Richmond、California、美国、94801
        • Kaiser Permanente Medical Center - Richmond
      • Roseville、California、美国、95661
        • Kaiser Permanente Medical Center - Roseville
      • Sacramento、California、美国、95817
        • University of California Davis Cancer Center
      • Sacramento、California、美国、95823
        • South Sacramento Kaiser-Permanente Medical Center
      • Sacramento、California、美国、95825
        • Kaiser Permanente Medical Center - Sacramento
      • San Francisco、California、美国、94115
        • Kaiser Permanente Medical Center - San Francisco Geary Campus
      • San Francisco、California、美国、94118
        • California Pacific Medical Center - California Campus
      • San Jose、California、美国、95119
        • Kaiser Permanente Medical Center - Santa Teresa
      • San Rafael、California、美国、94903
        • Sutter Health - Western Division Cancer Research Group
      • San Rafael、California、美国、94903
        • Kaiser Foundation Hospital - San Rafael
      • Santa Clara、California、美国、95051
        • Kaiser Permanente Medical Center - Santa Clara Kiely Campus
      • Santa Rosa、California、美国、95403
        • Kaiser Permanente Medical Center - Santa Rosa
      • South San Francisco、California、美国、94080
        • Kaiser Permanente Medical Center - South San Francisco
      • Stockton、California、美国、95210
        • Kaiser Permanente Medical Facility - Stockton
      • Truckee、California、美国、96161
        • Tahoe Forest Cancer Center
      • Vacaville、California、美国、95688
        • Kaiser Permanente Medical Center - Vacaville
      • Vallejo、California、美国、94589
        • Sutter Solano Medical Center
      • Vallejo、California、美国、94589
        • Kaiser Permanente Medical Center - Vallejo
      • Walnut Creek、California、美国、94596
        • Kaiser Permanente Medical Center - Walnut Creek
    • Connecticut
      • Hartford、Connecticut、美国、06105
        • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    • Georgia
      • Atlanta、Georgia、美国、30309
        • Piedmont Hospital
      • Atlanta、Georgia、美国、30342-1611
        • Northside Hospital Cancer Center
      • Atlanta、Georgia、美国、30342-1701
        • Saint Joseph's Hospital of Atlanta
      • Atlanta、Georgia、美国、30342
        • CCOP - Atlanta Regional
      • Austell、Georgia、美国、30106
        • WellStar Cobb Hospital
      • Columbus、Georgia、美国、31904
        • John B. Amos Cancer Center
      • Decatur、Georgia、美国、30033
        • Charles B. Eberhart Cancer Center at DeKalb Medical Center
      • Fayetteville、Georgia、美国、30214
        • Piedmont Fayette Hospital
      • Gainesville、Georgia、美国、30501
        • Northeast Georgia Medical Center
      • Lawrenceville、Georgia、美国、30045
        • Gwinnett Medical Center
      • Marietta、Georgia、美国、30060
        • Kennestone Cancer Center at Wellstar Kennestone Hospital
      • Riverdale、Georgia、美国、30274-2600
        • Southern Regional Medical Center
      • Rome、Georgia、美国、30165
        • Harbin Clinic Cancer Center - Medical Oncology
    • Hawaii
      • Honolulu、Hawaii、美国、96819
        • Kaiser Permanente - Moanalua Medical Center and Clinic
    • Illinois
      • Decatur、Illinois、美国、62526
        • Decatur Memorial Hospital Cancer Care Institute
      • Maywood、Illinois、美国、60153
        • Cardinal Bernardin Cancer Center at Loyola University Medical Center
      • Springfield、Illinois、美国、62781-0001
        • Regional Cancer Center at Memorial Medical Center
    • Kansas
      • Chanute、Kansas、美国、66720
        • Cancer Center of Kansas, PA - Chanute
      • Dodge City、Kansas、美国、67801
        • Cancer Center of Kansas, PA - Dodge City
      • El Dorado、Kansas、美国、67042
        • Cancer Center of Kansas, PA - El Dorado
      • Fort Scott、Kansas、美国、66701
        • Cancer Center of Kansas - Fort Scott
      • Independence、Kansas、美国、67301
        • Cancer Center of Kansas-Independence
      • Kingman、Kansas、美国、67068
        • Cancer Center of Kansas, PA - Kingman
      • Lawrence、Kansas、美国、66044
        • Lawrence Memorial Hospital
      • Liberal、Kansas、美国、67901
        • Cancer Center of Kansas, PA - Liberal
      • Newton、Kansas、美国、67114
        • Cancer Center of Kansas, PA - Newton
      • Parsons、Kansas、美国、67357
        • Cancer Center of Kansas, PA - Parsons
      • Pratt、Kansas、美国、67124
        • Cancer Center of Kansas, PA - Pratt
      • Salina、Kansas、美国、67401
        • Cancer Center of Kansas, PA - Salina
      • Salina、Kansas、美国、67401
        • Tammy Walker Cancer Center at Salina Regional Health Center
      • Topeka、Kansas、美国、66606
        • Cotton-O'Neil Cancer Center
      • Wellington、Kansas、美国、67152
        • Cancer Center of Kansas, PA - Wellington
      • Wichita、Kansas、美国、67208
        • Cancer Center of Kansas, PA - Medical Arts Tower
      • Wichita、Kansas、美国、67214
        • Cancer Center of Kansas, PA - Wichita
      • Wichita、Kansas、美国、67214
        • CCOP - Wichita
      • Wichita、Kansas、美国、67214
        • Via Christi Cancer Center at Via Christi Regional Medical Center
      • Wichita、Kansas、美国、67208
        • Associates in Womens Health, PA - North Review
      • Winfield、Kansas、美国、67156
        • Cancer Center of Kansas, PA - Winfield
    • Kentucky
      • Lexington、Kentucky、美国、40536-0093
        • Lucille P. Markey Cancer Center at University of Kentucky
    • Michigan
      • Ann Arbor、Michigan、美国、48106-0995
        • Saint Joseph Mercy Cancer Center
      • Ann Arbor、Michigan、美国、48106
        • CCOP - Michigan Cancer Research Consortium
      • Battle Creek、Michigan、美国、49017
        • Battle Creek Health System Cancer Care Center
      • Big Rapids、Michigan、美国、49307
        • Mecosta County Medical Center
      • Dearborn、Michigan、美国、48123-2500
        • Oakwood Cancer Center at Oakwood Hospital and Medical Center
      • Flint、Michigan、美国、48503
        • Hurley Medical Center
      • Flint、Michigan、美国、48503
        • Genesys Hurley Cancer Institute
      • Grand Blanc、Michigan、美国、48439
        • Genesys Regional Medical Center
      • Grand Rapids、Michigan、美国、49503
        • Butterworth Hospital at Spectrum Health
      • Grand Rapids、Michigan、美国、49503
        • CCOP - Grand Rapids
      • Grand Rapids、Michigan、美国、49503
        • Lacks Cancer Center at Saint Mary's Health Care
      • Grosse Pointe Woods、Michigan、美国、48236
        • Van Elslander Cancer Center at St. John Hospital and Medical Center
      • Jackson、Michigan、美国、49201
        • Foote Memorial Hospital
      • Lansing、Michigan、美国、48912-1811
        • Sparrow Regional Cancer Center
      • Livonia、Michigan、美国、48154
        • St. Mary Mercy Hospital
      • Muskegon、Michigan、美国、49443
        • Mercy General Health Partners
      • Pontiac、Michigan、美国、48341-2985
        • St. Joseph Mercy Oakland
      • Port Huron、Michigan、美国、48060
        • Mercy Regional Cancer Center at Mercy Hospital
      • Saginaw、Michigan、美国、48601
        • Seton Cancer Institute at Saint Mary's - Saginaw
      • Traverse City、Michigan、美国、49684
        • Munson Medical Center
      • Warren、Michigan、美国、48093
        • St. John Macomb Hospital
      • Wyoming、Michigan、美国、49519
        • Metro Health Hospital
    • Montana
      • Billings、Montana、美国、59101
        • CCOP - Montana Cancer Consortium
      • Billings、Montana、美国、59101
        • St. Vincent Healthcare Cancer Care Services
      • Billings、Montana、美国、59107-7000
        • Billings Clinic - Downtown
      • Billings、Montana、美国、59102
        • Hematology-Oncology Centers of the Northern Rockies - Billings
      • Bozeman、Montana、美国、59715
        • Bozeman Deaconess Cancer Center
      • Butte、Montana、美国、59701
        • St. James Healthcare Cancer Care
      • Great Falls、Montana、美国、59405
        • Great Falls Clinic - Main Facility
      • Great Falls、Montana、美国、59405-5309
        • Big Sky Oncology
      • Great Falls、Montana、美国、59405
        • Sletten Cancer Institute at Benefis Healthcare
      • Havre、Montana、美国、59501
        • Northern Montana Hospital
      • Helena、Montana、美国、59601
        • St. Peter's Hospital
      • Kalispell、Montana、美国、59901
        • Kalispell Regional Medical Center
      • Kalispell、Montana、美国、59901
        • Glacier Oncology, PLLC
      • Kalispell、Montana、美国、59901
        • Kalispell Medical Oncology at KRMC
      • Missoula、Montana、美国、59807-7877
        • Montana Cancer Specialists at Montana Cancer Center
      • Missoula、Montana、美国、59807
        • Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    • North Carolina
      • Goldsboro、North Carolina、美国、27534
        • Wayne Memorial Hospital, Incorporated
      • Hendersonville、North Carolina、美国、28791
        • Pardee Memorial Hospital
    • Ohio
      • Bellefontaine、Ohio、美国、43311
        • Mary Rutan Hospital
      • Chillicothe、Ohio、美国、45601
        • Adena Regional Medical Center
      • Columbus、Ohio、美国、43214-3998
        • Riverside Methodist Hospital Cancer Care
      • Columbus、Ohio、美国、43222
        • Mount Carmel Health - West Hospital
      • Columbus、Ohio、美国、43215
        • CCOP - Columbus
      • Columbus、Ohio、美国、43215
        • Grant Medical Center Cancer Care
      • Columbus、Ohio、美国、43228
        • Doctors Hospital at Ohio Health
      • Delaware、Ohio、美国、43015
        • Grady Memorial Hospital
      • Lancaster、Ohio、美国、43130
        • Fairfield Medical Center
      • Marietta、Ohio、美国、45750
        • Strecker Cancer Center at Marietta Memorial Hospital
      • Mount Vernon、Ohio、美国、43050
        • Knox Community Hospital
      • Newark、Ohio、美国、43055
        • Licking Memorial Cancer Care Program at Licking Memorial Hospital
      • Springfield、Ohio、美国、45505
        • Community Hospital of Springfield and Clark County
      • Westerville、Ohio、美国、43081
        • Mount Carmel St. Ann's Cancer Center
      • Zanesville、Ohio、美国、43701
        • Genesis - Good Samaritan Hospital
    • South Carolina
      • Charleston、South Carolina、美国、29425
        • Hollings Cancer Center at Medical University of South Carolina
    • Utah
      • American Fork、Utah、美国、84003
        • American Fork Hospital
      • Cedar City、Utah、美国、84720
        • Sandra L. Maxwell Cancer Center
      • Logan、Utah、美国、84321
        • Logan Regional Hospital
      • Murray、Utah、美国、84157
        • Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
      • Ogden、Utah、美国、84403
        • Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
      • Provo、Utah、美国、84604
        • Utah Valley Regional Medical Center - Provo
      • Saint George、Utah、美国、84770
        • Dixie Regional Medical Center - East Campus
      • Salt Lake City、Utah、美国、84143
        • LDS Hospital
      • Salt Lake City、Utah、美国、84106
        • Utah Cancer Specialists at UCS Cancer Center
    • Washington
      • Bellingham、Washington、美国、98225
        • St. Joseph Cancer Center
      • Bremerton、Washington、美国、98310
        • Olympic Hematology and Oncology
      • Kennewick、Washington、美国、99336
        • Columbia Basin Hematology
      • Mount Vernon、Washington、美国、98274
        • Skagit Valley Hospital Cancer Care Center
      • Poulsbo、Washington、美国、98370
        • Harrison Poulsbo Hematology and Onocology
      • Seattle、Washington、美国、98109
        • Fred Hutchinson Cancer Research Center
      • Seattle、Washington、美国、98104
        • Harborview Medical Center
      • Seattle、Washington、美国、98104
        • Minor and James Medical, PLLC
      • Seattle、Washington、美国、98112
        • Group Health Central Hospital
      • Seattle、Washington、美国、98122-4307
        • Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
      • Seattle、Washington、美国、98195
        • University Cancer Center at University of Washington Medical Center
      • Spokane、Washington、美国、99202
        • Cancer Care Northwest - Spokane South
      • Spokane、Washington、美国、99218
        • Evergreen Hematology and Oncology, PS
      • Wenatchee、Washington、美国、98801-2028
        • Wenatchee Valley Medical Center
    • Wyoming
      • Sheridan、Wyoming、美国、82801
        • Welch Cancer Center at Sheridan Memorial Hospital

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 120年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

DISEASE CHARACTERISTICS:

  • Biopsy-proven* bronchioloalveolar carcinoma (BAC) or BAC variants (e.g., adenocarcinoma with BAC features, BAC with invasive adenocarcinoma) meeting the following criteria:

    • Incompletely resected or unresectable disease
    • No component of squamous cell carcinoma

    • Disease staged as 1 of the following:

      • Stage IIIB disease (T4 [cytologically confirmed malignant pleural effusion OR pleural tumor foci that are separate from direct pleural invasion by the primary tumor], any N, M0)

      • Stage IV disease (any T, any N, M1 [distant metastases present])

        • Recurrent disease in a separate lobe after prior resection within the past 5 years; multifocal lesions in > 1 lobe; or any disease that is recurrent after surgery or radiotherapy is considered stage IV disease
    • Tumor may be multifocal or diffuse NOTE: *Cytology specimens, including bronchial brushing, washings, or fine needle aspiration specimens, alone are not acceptable for diagnosis

  • Measurable or nonmeasurable disease by chest CT scan

    • Pleural effusions, ascites, and laboratory parameters are not acceptable as only evidence of disease
    • Disease must be present outside field of prior radiotherapy OR a new lesion must be inside port
  • Treated brain metastases allowed provided the patient is asymptomatic and do not require steroids

PATIENT CHARACTERISTICS:

  • Zubrod performance status 0-2
  • Absolute neutrophil count ≥ 1,500/mm³
  • Platelet count ≥ 100,000/mm³
  • Total bilirubin normal
  • AST or AST ≤ 2.5 times upper limit of normal (ULN) (5 times ULN if liver metastases are present)
  • Alkaline phosphatase ≤ 2.5 times ULN (5 times ULN if bone metastases are present)
  • Creatinine ≤ 1.5 times ULN OR creatinine clearance ≥ 50 mL/min
  • Urine protein:creatinine ratio ≤ 0.5 OR urine protein < 1 g by 24-hour urine collection
  • Willing to provide prior smoking history
  • No hemoptysis ≥ ½ teaspoon within the past 28 days
  • No clinical history of pulmonary or upper respiratory hemorrhage > grade 2 within the past 6 months or > grade 1 within the past 28 days
  • No history of thromboses or hemorrhage, including hemorrhagic or thrombotic stroke, or other CNS bleeding
  • No uncontrolled hypertension
  • No serious nonhealing wound, ulcer, or bone fracture

  • No other prior malignancy except for any of the following:

    • Adequately treated basal cell or squamous cell skin cancer
    • In situ cervical cancer
    • Adequately treated stage I or II cancer that is currently in complete remission
    • Any other cancer from which the patient has been disease free for 5 years
  • Not pregnant or nursing
  • Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
  • Recovered from prior therapy
  • At least 28 days since prior radiotherapy (14 days for palliative radiotherapy)
  • At least 28 days since prior surgery (thoracic or other major surgeries)
  • More than 7 days since prior fine-needle aspiration or core biopsy
  • At least 28 days since prior systemic chemotherapy or biologic therapy
  • No prior gefitinib hydrochloride, erlotinib hydrochloride, or bevacizumab
  • No other prior anti-epidermal growth factor receptor or anti-vascular endothelial growth factor therapies
  • Concurrent stable, therapeutic anticoagulation therapy allowed (i.e., warfarin or low molecular weight heparin), provided the patient has no history of bleeding complications on anticoagulation or an inability to establish a stable therapeutic regimen for anticoagulation
  • No other concurrent anticancer therapy, including surgery, chemotherapy, hormone therapy, biologic therapy, or radiotherapy

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

  • 主要用途：治疗
  • 分配：不适用
  • 介入模型：单组作业
  • 屏蔽：无（打开标签）

武器和干预

参与者组/臂
干预/治疗
实验性的：Erlotinib and Bevacizumab
生物：贝伐单抗
药品：盐酸厄洛替尼

研究衡量的是什么？

主要结果指标

结果测量
大体时间
Overall Survival
大体时间：From date of registration to maximum of 3 years
From date of registration to maximum of 3 years

次要结果测量

结果测量
措施说明
大体时间
Progression-free Survival
大体时间：From date of registration to maximum of 3 years
From date of registration to maximum of 3 years
Response as Assessed by RECIST Criteria vs Central Computer-assisted Image-analysis System in Patients With Measurable Disease
大体时间：From date of registration to maximum of 3 years
Images for response assessed by the central computer-assisted image-analysis system were never collected.
From date of registration to maximum of 3 years
Frequency and Severity of Toxicities
大体时间：From date of registration to maximum of 3 years
From date of registration to maximum of 3 years

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

Southwest Oncology Group

合作者

National Cancer Institute (NCI)

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

  • West HJ, Moon J, Hirsch FR, et al.: SWOG S0635 and S0636: Phase II trials in advanced-stage NSCLC of erlotinib (OSI-774) and bevacizumab in bronchioloalveolar carcinoma (BAC) and adenocarcinoma with BAC features (adenoBAC), and in never-smokers with primary NSCLC adenocarcinoma (adenoCa). [Abstract] J Clin Oncol 30 (Suppl 15): A-7517, 2012.

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2007年7月1日

初级完成 (实际的)

2019年7月20日

研究完成 (实际的)

2019年8月20日

研究注册日期

首次提交

2007年2月15日

首先提交符合 QC 标准的

2007年2月15日

首次发布 (估计)

2007年2月19日

研究记录更新

最后更新发布 (实际的)

2020年4月2日

上次提交的符合 QC 标准的更新

2020年3月20日

最后验证

2020年3月1日

更多信息

与本研究相关的术语

关键字

其他相关的 MeSH 术语

其他研究编号

  • CDR0000529756
  • U10CA032102 (美国 NIH 拨款/合同)
  • S0635 (其他标识符：SWOG)

此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.

贝伐单抗的临床试验

搜索类似试验

赞助者和合作者

医疗条件

药物干预

CROs by country

CROs in Armenia

条件

罕见疾病

药物干预

膳食补充剂

赞助者/合作者

地点

3
订阅